TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive Witnesses Seek 15% Boost For NCI In 1998 as First Step to 100% Raise Over 5 Years May 9, 1997